Nick
Analyst
Cantor Fitzgerald
Equibles does not estimate personal net worth.
About Nick
Nick is recorded as Analyst at Cantor Fitzgerald. Nick has spoken on 1 investor event across 1 company, most recently for Opus Genetics, Inc. on September 9, 2026. The companies whose calls Nick spoke on are classified in the Healthcare sector.
Nick on recent calls
“For the pivotal study, is there a maximum number of loci that can be pre-specified along the transitional zone? And also, will the loci be selected on a patient-level basis in a targeted manner to inform the physician at where to place the bloods?”
Affiliation history
-
Cantor Fitzgerald
Analyst
Transcript header (unverified)
Current